FI954734A0 - Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina - Google Patents

Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina

Info

Publication number
FI954734A0
FI954734A0 FI954734A FI954734A FI954734A0 FI 954734 A0 FI954734 A0 FI 954734A0 FI 954734 A FI954734 A FI 954734A FI 954734 A FI954734 A FI 954734A FI 954734 A0 FI954734 A0 FI 954734A0
Authority
FI
Finland
Prior art keywords
5ht1a
ligands
indole derivatives
indole
derivatives
Prior art date
Application number
FI954734A
Other languages
English (en)
Swedish (sv)
Other versions
FI954734A (fi
Inventor
Myrna Gil Quintero
Vincenzo Martino
Franco Borsini
Carlo Maria Pellegrini
Marco Turconi
Ettore Giraldo
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of FI954734A0 publication Critical patent/FI954734A0/fi
Publication of FI954734A publication Critical patent/FI954734A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
FI954734A 1993-04-08 1995-10-05 Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina FI954734A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI930699A IT1271352B (it) 1993-04-08 1993-04-08 Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
PCT/EP1994/001016 WO1994024125A1 (en) 1993-04-08 1994-03-31 Indole derivatives as 5-ht1a and/or 5-ht2 ligands

Publications (2)

Publication Number Publication Date
FI954734A0 true FI954734A0 (fi) 1995-10-05
FI954734A FI954734A (fi) 1995-10-05

Family

ID=11365694

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954734A FI954734A (fi) 1993-04-08 1995-10-05 Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina

Country Status (20)

Country Link
US (1) US5834493A (fi)
EP (1) EP0694033A1 (fi)
JP (1) JPH08508738A (fi)
CN (1) CN1124960A (fi)
AU (1) AU684276B2 (fi)
BG (1) BG100040A (fi)
BR (1) BR9406206A (fi)
CA (1) CA2160020A1 (fi)
CZ (1) CZ283398B6 (fi)
FI (1) FI954734A (fi)
HU (1) HUT74090A (fi)
IL (1) IL109234A (fi)
IT (1) IT1271352B (fi)
NO (1) NO953967L (fi)
NZ (1) NZ265055A (fi)
PL (1) PL310995A1 (fi)
SG (1) SG50507A1 (fi)
SK (1) SK119795A3 (fi)
WO (1) WO1994024125A1 (fi)
ZA (1) ZA942383B (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420521D0 (en) * 1994-10-12 1994-11-30 Smithkline Beecham Plc Novel compounds
CN1243001C (zh) * 1997-05-09 2006-02-22 H·隆德贝克有限公司 制造司提多尔的方法
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
EP1047692B1 (en) 1998-01-14 2004-07-21 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
US6133287A (en) * 1998-03-24 2000-10-17 Allelix Biopharmaceuticals Inc. Piperidine-indole compounds having 5-HT6 affinity
ATE223379T1 (de) * 1998-04-08 2002-09-15 Wyeth Corp N-aryloxyethylaminderivate zur behandlung der depression
CN1307576A (zh) * 1998-04-29 2001-08-08 美国家用产品公司 5-羟色胺能药物
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
DE19951360A1 (de) * 1999-10-26 2001-05-03 Aventis Pharma Gmbh Substituierte Indole
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
ES2264994T3 (es) 2000-12-22 2007-02-01 Wyeth Compuestos heterociclilalquilindol o -azaindol como ligandos de 5-hidroxitriptamina-6.
US7135479B2 (en) 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
EP2560676B8 (en) 2010-04-22 2016-10-12 Intra-Cellular Therapies, Inc. Organic compounds
CA2870303A1 (en) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc. Organic compounds
EP2968320B1 (en) 2013-03-15 2020-11-11 Intra-Cellular Therapies, Inc. Organic compounds
KR20230058736A (ko) 2013-12-03 2023-05-03 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
JP2017509677A (ja) 2014-04-04 2017-04-06 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
EP3125893B1 (en) 2014-04-04 2023-09-20 Intra-Cellular Therapies, Inc. Deuterated heterocycle fused gamma-carbolines as antagonists of 5-ht2a receptors
EP3331530A4 (en) * 2015-08-03 2018-12-19 Raze Therapeutics Inc. Mthfd2 inhibitors and uses thereof
PT3407888T (pt) 2016-01-26 2021-03-19 Intra Cellular Therapies Inc Compostos de piridopirroloquinoxalina, suas composições e utilizações
IL297676B2 (en) 2016-03-25 2023-12-01 Intra Cellular Therapies Inc A controlled or delayed release pharmaceutical preparation containing a deuterated compound
EP3436083A4 (en) 2016-03-28 2019-11-27 Intra-Cellular Therapies, Inc. NEW COMPOSITIONS AND METHODS
WO2018071233A1 (en) 2016-10-12 2018-04-19 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
IL304026A (en) 2017-03-24 2023-08-01 Intra Cellular Therapies Inc New preparations and methods
IL272249B2 (en) 2017-07-26 2023-11-01 Intra Cellular Therapies Inc organic compounds
CN111093664B (zh) 2017-07-26 2023-06-02 细胞内治疗公司 有机化合物
BR112021003655A2 (pt) 2018-08-31 2021-05-18 Intra-Cellular Therapies, Inc. métodos novos
BR112021003838A2 (pt) 2018-08-31 2021-05-18 Intra-Cellular Therapies, Inc. métodos novos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
AU651637B2 (en) * 1990-10-15 1994-07-28 Pfizer Inc. Indole derivatives
JP3140155B2 (ja) * 1992-03-09 2001-03-05 杏林製薬株式会社 N,n’−ジ置換アミド誘導体
TW226019B (fi) * 1992-03-23 1994-07-01 Sankyo Co

Also Published As

Publication number Publication date
IL109234A0 (en) 1994-07-31
ITMI930699A0 (it) 1993-04-08
WO1994024125A1 (en) 1994-10-27
ITMI930699A1 (it) 1994-10-08
CZ283398B6 (cs) 1998-04-15
NO953967L (no) 1995-12-05
NZ265055A (en) 1996-09-25
HUT74090A (en) 1996-11-28
FI954734A (fi) 1995-10-05
AU684276B2 (en) 1997-12-11
US5834493A (en) 1998-11-10
IL109234A (en) 1998-04-05
NO953967D0 (no) 1995-10-05
IT1271352B (it) 1997-05-27
SK119795A3 (en) 1996-04-03
BG100040A (bg) 1996-03-29
HU9502913D0 (en) 1995-11-28
PL310995A1 (en) 1996-01-22
JPH08508738A (ja) 1996-09-17
SG50507A1 (en) 1998-07-20
CN1124960A (zh) 1996-06-19
CZ260295A3 (en) 1996-01-17
ZA942383B (en) 1995-10-09
EP0694033A1 (en) 1996-01-31
AU6538294A (en) 1994-11-08
BR9406206A (pt) 1996-02-06
CA2160020A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
FI954734A (fi) Indolijohdannaiset 5HT1A ja/tai 5-HT2 ligandeina
NO943913D0 (no) Indol-derivater
FI944969A (fi) Indolijohdannaisia
NO961475D0 (no) Indol-derivater
GB9326332D0 (en) Indole derivatives
GB9319297D0 (en) Indole derivatives
DE69212058T2 (de) Indol-Derivate
NO308236B1 (no) Farmasøytisk blanding inneholdende indolderivater
FI955164A0 (fi) Heterosykliset johdannaiset
ITMI951900A0 (it) Derivati idroisochinolinici sostituiti
BR9408029A (pt) Derivados de 3-azabicicloalcanos N-substituídos
DK0725061T3 (da) Substituerede indolderivater
ITMI941191A0 (it) 1-b-metil-2-tiol carbapen derivati
NO934473D0 (no) N-substituerte azabicykloheptanderivater
DE59605373D1 (de) Substituierte Indol-Derivate
ITMI930473A1 (it) Derivati idantoinici
ITMI950495A0 (it) Derivati chinolinici
ITMI950494A0 (it) Derivati chinolinici
GB9309148D0 (en) Indole derivatives
GB9310092D0 (en) Indole derivatives
GB9319299D0 (en) Indole derivatives